<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">pharmjournal</journal-id><journal-title-group><journal-title xml:lang="ru">Разработка и регистрация лекарственных средств</journal-title><trans-title-group xml:lang="en"><trans-title>Drug development &amp; registration</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2305-2066</issn><issn pub-type="epub">2658-5049</issn><publisher><publisher-name>LLC «CPHA»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.33380/2305-2066-2021-10-1-136-141</article-id><article-id custom-type="elpub" pub-id-type="custom">pharmjournal-874</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>РЕГУЛЯТОРНЫЕ ВОПРОСЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REGULATORY ISSUES</subject></subj-group></article-categories><title-group><article-title>Методические рекомендации по содействию внедрению фармацевтических систем качества на предприятиях ЕАЭС через управление вовлеченностью производственного персонала</article-title><trans-title-group xml:lang="en"><trans-title>Guidelines for Promoting the Implementation of Pharmaceutical Quality Systems at EAEU Enterprises Through the Management of the Engagement of Production Personnel</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7206-3313</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Смирнов</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Smirnov</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Смирнов Владимир А.</p><p>109044, г. Москва, Лавров пер., д. 6</p></bio><bio xml:lang="en"><p>Vladimir A. Smirnov</p><p>6, Lavrov lane, Moscow, 109044</p></bio><email xlink:type="simple">smirnovs3000@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1069-8647</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Горячкин</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Goryachkin</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>109044, г. Москва, Лавров пер., д. 6</p></bio><bio xml:lang="en"><p>Vyacheslav V. Goryachkin</p><p>6, Lavrov lane, Moscow, 109044</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7929-4982</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шестаков</surname><given-names>В. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Shestakov</surname><given-names>V. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>109044, г. Москва, Лавров пер., д. 6</p></bio><bio xml:lang="en"><p>Vladislav N. Shestakov</p><p>6, Lavrov lane, Moscow, 109044</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1784-881X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Абрамович</surname><given-names>Р. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Abramovich</surname><given-names>R. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>117198, г. Москва, ул. Миклухо-Маклая, д. 6</p></bio><bio xml:lang="en"><p>Rimma A. Abramovich</p><p>6, Mikluho-Maklaya str., Moscow, 117198</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФБУ «Государственный институт лекарственных средств и надлежащих практик» (ФБУ «ГИЛС и НП») Минпромторга России</institution></aff><aff xml:lang="en"><institution>State Institute of Drugs and Good Practices</institution></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГАОУ ВО «Российский университет дружбы народов» (Российский университет дружбы народов, РУДН)</institution></aff><aff xml:lang="en"><institution>Peoples Friendship University of Russia (RUDN University)</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>13</day><month>01</month><year>2021</year></pub-date><volume>10</volume><issue>1</issue><fpage>136</fpage><lpage>141</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Смирнов В.А., Горячкин В.В., Шестаков В.Н., Абрамович Р.А., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Смирнов В.А., Горячкин В.В., Шестаков В.Н., Абрамович Р.А.</copyright-holder><copyright-holder xml:lang="en">Smirnov V.A., Goryachkin V.V., Shestakov V.N., Abramovich R.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.pharmjournal.ru/jour/article/view/874">https://www.pharmjournal.ru/jour/article/view/874</self-uri><abstract><sec><title>Введение</title><p>Введение. Публикация посвящена актуальной организационно-кадровой проблематике внедрения фармацевтической системы качества (ФСК). Актуальность исследования обусловлена высокой значимостью обеспечения качества при разработке, производстве и выпуске в обращение лекарственных средств.</p></sec><sec><title>Цель</title><p>Цель. Целью исследования является разработка методических рекомендациий по организационно-кадровому содействию внедрению фармацевтических систем качества на предприятиях Евразийского союза (ЕАЭС) по выпуску лекарственных средств (ЛС) через инструментарий вовлеченности производственного персонала в развитие ФСК.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Вовлеченность персонала оценивалась на основании индекса вовлеченности; при изучении влияния вовлеченности производственного персонала на экономические показатели корпоративного развития использован метод бенчмаркинга (показатели вовлеченности и связанные с ними экономические показатели компаний «Акрихин», «Озон» сравнивались с панелью аналогичных показателей по 12 фармпредприятиям ЕАЭС).</p></sec><sec><title>Результаты и обсуждение</title><p>Результаты и обсуждение. Констатируется важная роль обеспечения повышения вовлеченности производственного персонала в развитие ФСК как инструмента устойчивого обеспечения результативности внедрения ФСК и стандартов надлежащей производственной практики (GMP) на предприятиях по выпуску лекарственных средств. С учетом опыта формирования «кружков качества» в классическом японском менеджменте предложен инновационный инструментарий управления вовлеченностью производственного персонала, основанный на формировании сообществ работников, координации и управления их вовлеченностью и развитием через корпоративный портал фармацевтического предприятия, а также членство в закрытых клубах лидеров по качеству.</p></sec><sec><title>Заключение</title><p>Заключение. Управление сообществами (малыми группами) производственных работников рассматривается как инструмент совершенствования организационно-кадрового обеспечения внедрения и совершенствования ФСК/GMP у фармпроизводителей ЕАЭС. Через сообщества предлагается осуществлять одновременно управление вовлеченностью, лояльностью и удовлетворенностью трудом производственного персонала; участники сообществ через обмен лучшими производственными практиками, идеями и мнениями по поводу развития ФСК и улучшения практик неуклонного обеспечения качества будут стимулировать себя и других производственных работников на неуклонное обеспечение качества выпускаемых ЛС. В качестве ожидаемого результата – неуклонный рост качества выпускаемых ЛС, приверженности производственного персонала философии качества, создание условий для роста производительности труда производственного персонала фармацевтических предприятий.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Introduction</title><p>Introduction. The publication is devoted to the topical organizational and personnel issues of the implementation of the pharmaceutical quality system (PQS). The relevance of the study is due to the high importance of quality assurance in the development, production and release of drugs into circulation.</p></sec><sec><title>Aim</title><p>Aim. The aim: to develop guidelines for organizational and personnel assistance in the implementation of pharmaceutical quality systems at enterprises of the Eurasian Union (EAEU) for the production of medicines (drugs) through the toolkit for engaging production personnel in the development of PQS.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. Personnel engagement was assessed based on the engagement index; the benchmarking method was used when studying the impact of the engagement of production personnel on the economic indicators of corporate development (indicators of engagement and related economic indicators of “Akrikhin”, “Ozon” were compared with a panel of similar indicators for 12 pharmaceutical enterprises of the EAEU).</p></sec><sec><title>Results and discussion</title><p>Results and discussion. The important role of ensuring an increase in the engagement of production personnel in the development of PQS as a tool for sustainable provision of the effectiveness of the implementation of PQS and standards of good manufacturing practice (GMP) at drug production enterprises is stated. Taking into account the experience of forming quality circles in classical Japanese management, an innovative toolkit for managing the engagement of production personnel is proposed, based on the formation of employee communities, coordination and management of their engagement and development through the corporate portal of a pharmaceutical enterprise, as well as membership in closed clubs of ‘quality leaders’.</p></sec><sec><title>Conclusion</title><p>Conclusion. Management of communities (small groups) of production workers is considered as a tool for improving the organizational and personnel support for the implementation and improvement of PQS / GMP at the EAEU pharmaceutical manufacturers. Through the communities, it is proposed to simultaneously manage the engagement, loyalty and job satisfaction of production personnel; community members, through the exchange of best manufacturing practices, ideas and opinions on the development of PQS and the improvement of nuclear quality assurance practices, will stimulate themselves and other production workers to consistently ensure the quality of manufactured drugs. The expected result is a steady increase in the quality of manufactured drugs, adherence of production personnel to the quality philosophy, creation of conditions for the growth of labour productivity of production personnel of pharmaceutical enterprises.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>фармацевтическая система качества</kwd><kwd>надлежащие производственные практики</kwd><kwd>производственный персонал&#13;
фармацевтических предприятий</kwd><kwd>вовлеченность производственного персонала</kwd><kwd>качество лекарственных средств</kwd></kwd-group><kwd-group xml:lang="en"><kwd>pharmaceutical quality system</kwd><kwd>good manufacturing practices</kwd><kwd>production personnel of pharmaceutical enterprises</kwd><kwd>engagement of&#13;
production personnel</kwd><kwd>quality of medicines</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Работа выполнена при поддержке Программы 5-100.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Pai D. R., Kamath K., Subramanyam E. V., Shabaraya A. R. Personnel Training for Pharmaceutical Industry. International Journal of Pharmaceutical Quality Assurance. 2016;7(03):55–61.</mixed-citation><mixed-citation xml:lang="en">Pai D.R., Kamath K., Subramanyam E.V., Shabaraya A.R. Personnel Training for Pharmaceutical Industry. International Journal of Pharmaceutical Quality Assurance. 2016;7(03):55-61.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Lawler E. E. Total quality management and employee involvement: are they compatible? Academy of Management Perspectives. 1994;8(1):68–76. DOI: 10.5465/ame.1994.9411302396.</mixed-citation><mixed-citation xml:lang="en">Lawler E. E. Total quality management and employee involvement: are they compatible? Academy of Management Perspectives. 1994;8(1):68–76. DOI: 10.5465/ame.1994.9411302396.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Neirotti P. Work intensification and employee involvement in lean production: New light on a classic dilemma. The International Journal of Human Resource Management. 2020;31(15):1958–83. DOI: 10.1080/09585192.2018.1424016.</mixed-citation><mixed-citation xml:lang="en">Neirotti P. Work intensification and employee involvement in lean production: New light on a classic dilemma. The International Journal of Human Resource Management. 2020;31(15):1958–83. DOI: 10.1080/09585192.2018.1424016.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Sorenson S. How employee engagement drives growth. Gallup business journal. 2013;1:1–4.</mixed-citation><mixed-citation xml:lang="en">Sorenson S. How employee engagement drives growth. Gallup business journal. 2013;1:1–4.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Gildeeva G. N., Belostotskiy A. V., Andreeva D. M. Relevant Changes in the Pharmacovigilance System in Russia and the Eurasian Economic Union (EAEU) International Journal of Pharmaceutical Quality Assurance. 2019;10(03):34–37.</mixed-citation><mixed-citation xml:lang="en">Gildeeva G. N., Belostotskiy A. V., Andreeva D. M. Relevant Changes in the Pharmacovigilance System in Russia and the Eurasian Economic Union (EAEU) International Journal of Pharmaceutical Quality Assurance. 2019;10(03):34–37.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Macey W. H., Schneider B. The meaning of employee engagement. Industrial and organizational Psychology. 2008;1(1):3–10. DOI: 10.1111/j.1754-9434.2007.0002.x.</mixed-citation><mixed-citation xml:lang="en">Macey W. H., Schneider B. The meaning of employee engagement. Industrial and organizational Psychology. 2008;1(1):3–10. DOI: 10.1111/j.1754-9434.2007.0002.x.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Chiarini A. Relationships between total quality management and Six Sigma inside European manufacturing companies: a dedicated survey. International Journal of Productivity and Quality Management. 2013;11(2):179–194. DOI: 10.1504/IJPQM.2013.052023.</mixed-citation><mixed-citation xml:lang="en">Chiarini A. Relationships between total quality management and Six Sigma inside European manufacturing companies: a dedicated survey. International Journal of Productivity and Quality Management. 2013;11(2):179–194. DOI: 10.1504/IJPQM.2013.052023.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Bouwman-Boer Y., Andersen L. M. Pharmaceutical quality systems. In: Bouwman-Boer Y., Fenton-May V., Le Brun P. (eds). Practical Pharmaceutics. New York: Springer; 2015. P. 769–796. DOI: 10.1007/978-3-319-15814-3_35.</mixed-citation><mixed-citation xml:lang="en">Bouwman-Boer Y., Andersen L. M. Pharmaceutical quality systems. In: Bouwman-Boer Y., Fenton-May V., Le Brun P. (eds). Practical Pharmaceutics. New York: Springer; 2015. P. 769–796. DOI: 10.1007/978-3-319-15814-3_35.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Oluwadare O. P., Ola-Olorun O. J., Oluwale B. A. Assessment of Total Quality Management Adoption Level in Pharmaceutical Manufacturing Companies in Southwestern Nigeria. JERA 2019;43:168– 177. DOI: 10.4028/www.scientific.net/jera.43.168.</mixed-citation><mixed-citation xml:lang="en">Oluwadare O.P., Ola-Olorun O.J., Oluwale B.A. Assessment of Total Quality Management Adoption Level in Pharmaceutical Manufacturing Companies in Southwestern Nigeria. JERA 2019;43:168–77. DOI:10.4028/www.scientific.net/jera.43.168.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Jyoti S., Sarthak S. Human Resource Management in Japan. Advances in Management. 2019;12(1):48–53.</mixed-citation><mixed-citation xml:lang="en">Jyoti S., Sarthak S. Human Resource Management in Japan. Advances in Management. 2019;12(1):48–53.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
